ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
How Merck's desire for more 'control' became a $2.7B ArQule buy fiercepharma
December 20, 2019It’s not uncommon for partnership talks focused on one drug to escalate into a full-on buyout. And that's just what happened with Merck & Co.’s $2.7 billion deal for ArQule. -
Merck to Acquire ArQule americanpharmaceuticalreview
December 12, 2019Merck and ArQule announced the companies have entered into a definitive agreement under which Merck, through a subsidiary ... -
Merck to acquire ArQule in $2.7bn deal pharmaceutical-technology
December 11, 2019Merck (MSD) has signed a definitive agreement to acquire biopharmaceutical company ArQule for a total cash consideration of $2.7bn, or $20 per share.
Pharma Sources Insight January 2025
